OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
62 hedge funds and large institutions have $120M invested in OptiNose in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 9 closing their positions.
300% more call options, than puts
Call options by funds: $4K | Put options by funds: $1K
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
58% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 12
13% more funds holding
Funds holding: 55 → 62 (+7)
3% more capital invested
Capital invested by funds: $116M → $120M (+$3.81M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.58% less ownership
Funds ownership: 57.39% → 55.8% (-1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
+$887K |
| 2 |
Millennium Management
New York
|
+$589K |
| 3 |
ECM
Element Capital Management
New York
|
+$588K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$435K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$360K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$3.69M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$940K |
| 3 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
-$730K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$99.3K |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$66.6K |
OPTN Hedge Fund Activity: Q1 2023 in Review
62 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q1 2023, worth a combined $120M — up 3.3% from $116M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new OPTN positions and 9 closed out — a net gain of 7 holders — while 19 added to existing stakes and 12 trimmed.
The largest buyer was Kingdon Capital Management, adding an estimated $887K. The largest seller was Armistice Capital, exiting entirely with an estimated $3.69M sold.
- 62 institutional investors held OptiNose (OPTN) as of Q1 2023, up from 55 in Q4 2022.
- Funds reported $120M of OptiNose stock for Q1 2023, up 3.3% quarter-over-quarter.
- 16 funds opened new OptiNose positions in Q1 2023 and 9 closed out, a net change of +7 holders.
- The largest OptiNose buyer in Q1 2023 was Kingdon Capital Management, an estimated $887K added.
- The largest OptiNose seller in Q1 2023 was Armistice Capital, an estimated $3.69M sold.
Based on aggregated 13F filings for Q1 2023.